E-LIB Suche - Ergebnisse für: Pestronk, Alan

1

104-week efficacy and safety of cipaglucosidase alfa plus m..:

Schoser, Benedikt ; Kishnani, Priya S. ; Bratkovic, Drago...
Journal of Neurology. 271 (2024) 5 - p. 2810-2823 , 2024

Link: https://doi.org/10.1007/..

2

Ophthalmoparesis as an unusual manifestation of anti-3‑hydr..:

Putko, Brendan ; Pestronk, Alan ; Van Stavern, Gregory P....
Neuromuscular Disorders. 42 (2024) - p. 1-4 , 2024

Link: https://doi.org/10.1016/..

3

Safety and efficacy of losmapimod in facioscapulohumeral mu..:

Tawil, Rabi ; Wagner, Kathryn R ; Hamel, Johanna I...
The Lancet Neurology. 23 (2024) 5 - p. 477-486 , 2024

Link: https://doi.org/10.1016/..

4

Schwann cells and myelin in human peripheral nerve: Major p..:

Pestronk, Alan ; Schmidt, Robert E. ; Bucelli, Robert.
Neuropathology and Applied Neurobiology. 49 (2023) 2 - p. , 2023

Link: https://doi.org/10.1111/..

5

Expanding the muscle imaging spectrum in dysferlinopathy: d..:

Llansó, Laura ; Moore, Ursula ; Bolano-Diaz, Carla...
Neuromuscular Disorders. 33 (2023) 4 - p. 349-357 , 2023

Link: https://doi.org/10.1016/..

6

Biallelic variants in COQ7 cause distal hereditary motor ne..:

Rebelo, Adriana P ; Tomaselli, Pedro J ; Medina, Jessica...
Brain. 146 (2023) 10 - p. 4191-4199 , 2023

Link: https://doi.org/10.1093/..

7

Myostatin and follistatin as monitoring and prognostic biom..:

Moore, Ursula ; Fernández-Simón, Esther ; Schiava, Marianela...
Neuromuscular Disorders. 33 (2023) 2 - p. 199-207 , 2023

Link: https://doi.org/10.1016/..

8

Randomized phase 2 study of ACE‐083, a muscle‐promoting age..:

Statland, Jeffrey M. ; Campbell, Craig ; Desai, Urvi...
Muscle & Nerve. 66 (2022) 1 - p. 50-62 , 2022

Link: https://doi.org/10.1002/..

9

Cardiac and pulmonary findings in dysferlinopathy: A 3‐year..:

Moore, Ursula ; Fernandez‐Torron, Roberto ; Jacobs, Marni...
Muscle & Nerve. 65 (2022) 5 - p. 531-540 , 2022

Link: https://doi.org/10.1002/..

10

Randomized Phase 2 Study of ACE-083 in Patients With Charco..:

Thomas, Florian P. ; Brannagan III, Thomas H. ; Butterfield, Russell J....
Neurology. 98 (2022) 23 - p. , 2022

Link: https://doi.org/10.1212/..

11

Whole Body MRI Quantitative muscle analysis to evaluate Eff..:

Mellion, Michelle ; Tawil, Rabi ; Statland, Jeffrey...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

12

Water T2 could predict functional decline in patients with ..:

Moore, Ursula ; Caldas de Almeida Araújo, Ericky ; Reyngoudt, Harmen...
Journal of Cachexia, Sarcopenia and Muscle. 13 (2022) 6 - p. 2888-2897 , 2022

Link: https://doi.org/10.1002/..

13

Sarcoidosis, granulomas and myopathy syndromes: A clinical-..:

Garret, Mark ; Pestronk, Alan
Journal of Neuroimmunology. 373 (2022) - p. 577975 , 2022

Link: https://doi.org/10.1016/..

14

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48..:

Tawil, Rabi ; Statland, Jeffrey ; Wang, Leo...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

15

Safety and efficacy of cipaglucosidase alfa plus miglustat ..:

Schoser, Benedikt ; Roberts, Mark ; Byrne, Barry J...
The Lancet Neurology. 20 (2021) 12 - p. 1027-1037 , 2021

Link: https://doi.org/10.1016/..